Tauro-α-muricholic acid

Overview

Tauro-α-muricholic acid (T-α-MCA) is a Taurine ( HY-B0351 )-conjugated primary Bile acid. Tauro-α-muricholic acid is a FXR antagonist with an IC 50 of 28 µM. Tauro-α-muricholic acid attenuates other bile acid-activated FXR signaling. Tauro-α-muricholic acid can be used in the research of Alzheimer's disease, glucose metabolism, and lipid metabolism.

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Endogenous Metabolite | Products > Signaling Pathways > FXR

Product Information

• Catalog No.: HY-133890
• CAS No.: 25613-05-2
• Molecular Formula: C26H45NO7S
• Molecular Weight: 515.70
• Purity: 99.18%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 1.67 mg/mL (3.24 mM); Clear solution
• Availability: In-stock

Source

Original product source